Quick Answer
ALX ONCOLOGY HOLDINGS INC reported Common Stock Shares Outstanding of 54.39 million shares for the year ending 2025.
- ALX ONCOLOGY HOLDINGS INC showed an increase of +2.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ALX ONCOLOGY HOLDINGS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), ALX ONCOLOGY HOLDINGS INC's Common Stock Shares Outstanding has grown by 1,617.4%.
- Historical annual values: Fiscal year 2025: 54.39 million shares | Fiscal year 2024: 53.05 million shares | Fiscal year 2023: 49.95 million shares | Fiscal year 2022: 40.86 million shares | Fiscal year 2021: 40.59 million shares | Fiscal year 2020: 39.84 million shares | Fiscal year 2019: 3.17 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: